Cargando…
Antibody–drug conjugates: Recent advances in payloads
Antibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads with efficient killing, show great clinical therapeutic value. The ADCs’ payloads play a key role in determining the efficacy of ADC drugs and thus have attracted great attentio...
Autores principales: | Wang, Zhijia, Li, Hanxuan, Gou, Lantu, Li, Wei, Wang, Yuxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547921/ https://www.ncbi.nlm.nih.gov/pubmed/37799390 http://dx.doi.org/10.1016/j.apsb.2023.06.015 |
Ejemplares similares
-
Antibody-Drug Conjugates Containing Payloads from Marine Origin
por: Cheng-Sánchez, Iván, et al.
Publicado: (2022) -
Payload diversification: a key step in the development of antibody–drug conjugates
por: Conilh, Louise, et al.
Publicado: (2023) -
Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins
por: Zhou, Qun
Publicado: (2023) -
Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates
por: Adhikari, Ajeeth, et al.
Publicado: (2021) -
Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload
por: Kondrashov, Aleksei, et al.
Publicado: (2023)